Koen Binnemans

YF[MoO4] and YCl[MoO4]: Two halide derivatives of yttrium ortho-oxomolybdate: Syntheses, structures, and luminescence properties

The halide derivatives of yttrium ortho-oxomolybdate YX[MoO 4] (X = F, Cl) both crystallize in the monoclinic system with four formula units per unit cell. YF[MoO 4] exhibits a primitive cell setting (space group P21/ c; a = 519.62(2) pm, b = 1225.14(7) pm, c = 663.30(3) pm, beta = 112.851(4) degrees ), whereas the lattice of YCl[MoO 4] shows face-centering (space group C2/m; a = 1019.02(5) pm, b = 720.67(4) pm, c = 681.50(3) pm, beta = 107.130(4) degrees ). The two compounds each contain crystallographically unique Y (3+) cations, which are found to have a coordination environment of six oxide and two halide anions. In the case of YF[MoO 4], the coordination environment is seen as square antiprisms, and for YCl[MoO 4], trigon-dodecahedra are found. The discrete tetrahedral [MoO 4] (2-) units of the fluoride derivative are exclusively bound by six terminal Y (3+) cations, while those of the chloride compound show a 5-fold coordination around the tetrahedra with one edge-bridging and four terminal Y (3+) cations. The halide anions in each compound exhibit a coordination number of two, building up isolated planar rhombus-shaped units according to [Y 2F 2] (4+) in YF[MoO 4] and [Y 2Cl 2] (4+) in YCl[MoO 4], respectively. Both compounds were synthesized at high temperatures using Y2O3, MoO3, and the corresponding yttrium trihalide in a molar ratio of 1:3:1. Single crystals of both are insensitive to moist air and are found to be coarse shaped and colorless with optical band gaps situated in the near UV around 3.78 eV for the fluoride and 3.82 eV for the chloride derivative. Furthermore, YF[MoO 4] seems to be a suitable material for doping to obtain luminescent materials because the Eu (3+)-doped compound shows an intense red luminescence, which has been spectroscopically investigated.

Crystal structure of tris(N-(n-butyl)-4-methoxy-2-hydroxybenzaldimine)-tris(nitrato)lanthanum(III), La (C12H17NO2)3(NO3)3

Abstract C36H51LaN6O15, triclinic, P1̅̅ (No. 2), a = 11.455(2) Å, b = 13.859(3) Å, c = 14.101(4) Å, α = 98.50(2)°, β = 98.87(1)°, γ = 92.52(2)°, V = 2182.4 Å3, Z = 2, Rgt(F) = 0.035, wRref(F2) = 0.082, T = 289 K.

Refinement of the crystal structure of dichloro-bis(pyridine-N)- copper(II), C10H10Cl2CuN2, at 100 K

Abstract C10H10Cl2CuN2, monoclinic, P121/n1 (No. 14), a = 3.7911(2) Å, b = 8.5205(3) Å, c = 16.9910(7) Å, β = 91.973(3)°, V = 548.5 Å3, Z = 2, Rgt(F) = 0.033, wRref(F2) = 0.086, T = 100 K.